Insider Selling: Liquidia (NASDAQ:LQDA) CEO Sells $859,891.96 in Stock

Liquidia Corporation (NASDAQ:LQDA) CEO Roger Jeffs sold 21,433 shares of the business’s stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $40.12, for a total value of $859,891.96. Following the sale, the chief executive officer owned 1,495,234 shares in the company, valued at approximately $59,988,788.08. The trade was a 1.41% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Roger Jeffs also recently made the following trade(s):

• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.14, for a total value of $1,003,500.00.
• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The shares were sold at an average price of $40.00, for a total value of $132,000.00.
• On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The shares were sold at an average price of $38.37, for a total value of $1,256,387.28.
• On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total value of $1,003,000.00.

Liquidia Stock Up 3.2%

Liquidia stock opened at $41.40 on Friday. The company has a debt-to-equity ratio of 2.97, a quick ratio of 1.84 and a current ratio of 2.01. The business’s 50-day simple moving average is $36.63 and its two-hundred day simple moving average is $33.14. The company has a market cap of $3.65 billion, a PE ratio of -49.88 and a beta of 0.45. Liquidia Corporation has a fifty-two week low of $11.85 and a fifty-two week high of $46.67.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings results on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.07. The business had revenue of $92.02 million for the quarter, compared to the consensus estimate of $87.49 million. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.The business’s revenue was up 3072.4% on a year-over-year basis. Equities analysts anticipate that Liquidia Corporation will post -1.51 EPS for the current year.

Hedge Funds Weigh In On Liquidia

Several hedge funds and other institutional investors have recently made changes to their positions in LQDA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Liquidia by 4.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock valued at $556,000 after acquiring an additional 1,700 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Liquidia by 10.7% in the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after acquiring an additional 82,955 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Liquidia by 15.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock valued at $1,796,000 after acquiring an additional 16,022 shares in the last quarter. Creative Planning lifted its position in shares of Liquidia by 40.7% in the second quarter. Creative Planning now owns 26,840 shares of the company’s stock valued at $334,000 after acquiring an additional 7,765 shares in the last quarter. Finally, Legal & General Group Plc lifted its position in shares of Liquidia by 13.4% in the second quarter. Legal & General Group Plc now owns 94,152 shares of the company’s stock valued at $1,174,000 after acquiring an additional 11,111 shares in the last quarter. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Key Stories Impacting Liquidia

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Earnings beat and improving near‑term fundamentals — Liquidia reported stronger‑than‑expected revenue and EPS for the quarter (revenue and EPS beat consensus), which supports upside vs. expectations and likely underpins buying momentum. MarketBeat: Liquidia Stock
• Positive Sentiment: Analyst support — multiple firms have reiterated or raised ratings/targets (including upgrades and higher price targets), giving institutional and retail buyers a constructive research backdrop. MarketBeat: Analyst Coverage
• Neutral Sentiment: High institutional ownership (~64.5%) and selective inflows — large holders can stabilize the stock, so insider sales don’t automatically translate into sustained selling pressure if institutions hold or add. MarketBeat: Institutional Holdings
• Negative Sentiment: Concentrated insider selling — several executives sold meaningful blocks of shares (CEO and CFO among them) under pre‑arranged Rule 10b5‑1 plans; the scale and timing of these sales can create negative investor perception despite being planned. SEC Filing: Kaseta Sale
• Negative Sentiment: CEO/C-suite sales add to concern — CEO Roger Jeffs disclosed multi‑date sales (including a 25,000‑share block), which, together with other officer transactions, may cap upside near recent highs. SEC Filing: Jeffs Sale

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on LQDA. Raymond James Financial restated a “strong-buy” rating on shares of Liquidia in a research note on Thursday, March 5th. Needham & Company LLC upped their target price on Liquidia from $52.00 to $54.00 and gave the stock a “buy” rating in a research note on Thursday, March 5th. Oppenheimer upped their target price on Liquidia from $16.00 to $19.00 and gave the stock an “underperform” rating in a research note on Thursday, March 12th. Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia in a research note on Thursday, January 22nd. Finally, Zacks Research downgraded Liquidia from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 27th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $43.44.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).